Evidence map›Paper›PMID 38072663›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Sequential-Crosslinking Fibrin Glue for Rapid and Reinforced Hemostasis.

Lisha Yu, Zhaodi Liu, Zongrui Tong, Yihang Ding, Zhefeng Qian, Weilin Wang, Zhengwei Mao, Yuan Ding

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Sequential-Crosslinking Fibrin Glue for Rapid and Reinforced Hemostasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lisha YuDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
Zhaodi LiuDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
Zongrui TongDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
Yihang DingMOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China.
Zhefeng QianDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
Weilin WangDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
Zhengwei MaoDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.ORCID 0000-0001-7990-2856
Yuan DingDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
Zhejiang Cancer Hospital · CNBlood Center of Zhejiang Province · CN

Funding

Central Guidance on Local Science and Technology Development Fund of Zhejiang Province 2023ZY1017Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province CXPJJH12000009-07Fundamental Research Funds for the Central Universities 226-2023-00038Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province 2020E10004Key Research and Development Program of Zhejiang Province 2021C03121National Natural Science Foundation of China 52273152National Natural Science Foundation of China 82001673National Natural Science Foundation of China 82072650National Natural Science Foundation of China 82202483National Natural Science Foundation of China 82272860Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study SN-ZJU-SIAS-006Zhejiang University Basic Research Fund 226-2022-00037
6 · The paper itself

Abstract

Achieving hemostasis effectively is essential for surgical success and excellent patient outcomes. However, it is challenging to develop hemostatic adhesives that are fast-acting, strongly adherent, long-lasting, and biocompatible for treating hemorrhage. In this study, a sequential crosslinking fibrin glue (SCFG) is developed, of which the first network of the fibrin glue forms in situ within 2 s to act as an initial physical barrier and locks the gelatin methacryloyl precursor for tight construction of the second network to enhance wet adhesion and durability for tissues covered with blood. The sequential crosslinking glue can provide large pressures (≈280 mmHg of burst pressure), makes strong (38 kPa of shear strength) and tough (≈60 J m

Indexed as

Fibrin Tissue AdhesiveHemostaticsAdhesivesAnimalsHemostasisHumansRabbitsRatsSwineAdhesivesFibrin Tissue AdhesiveHemostaticsbiomaterialsfibrin gluehemostasishydrogelsequential-crosslinking

Identifiers

PMID38072663
PMCPMC10870078
OpenAlexW4389526540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.